The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when resistance develops. The same principles of evolution drive the development of resistance in all of these contexts, yet each field attacks the problem of resistance alone. The Drug Resistance Gordon Research Conference (DRGRC) provides a unique forum where scientists and physicians working in infectious diseases, cancer and agriculture come together to discuss common issues and share approaches with the conviction that general strategies to minimize resistance can be developed by working together.
As in previous years, the conference strives to recruit a broad array of disciplinary expertise, varying seniority, and wide geographic and cultural perspectives. The organizers are recruiting internationally recognized speakers from infectious disease, cancer and agriculture, including representatives from academics, government organizations, and industry. The organizers also welcome – and will seek out – timely and novel poster presentations and at least twelve outstanding poster presentations will be selected for short oral talks.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by September 26, 2021. Please check back for updates.
- Keynote Session: Protecting New Drugs and Pesticides Against Resistance
- The Emergence of Resistance
- Systems and Modeling Strategies to Address Resistance
- Combating Resistance with Novel Targets
- Durable Drug Design
- Eco-Evolutionary Strategies to Address Resistance
- Threats and Responses
- Microbiome and Resistance
- Keynote Session: Emerging Strategies to Combat Resistance